Skip to main content

Full Schedule

Full Schedule

  • Wednesday, March 22, 2023
  • 8:45 AM – 10:00 AM
    (2) Biosimilar Regulatory and Practical Considerations When Selecting Biosimilar Use in the Marketplace
  • 8:45 AM – 10:00 AM
    (3) AMCP Partner Session: Managed Care Perspective on HIV Prevention - A Public Health Priority
  • 8:45 AM – 10:00 AM
    (4) Prior Authorization Criteria: Looking Beyond Clinical Trial Populations
  • 8:45 AM – 10:00 AM
    (5) Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's Disease
  • 8:45 AM – 10:00 AM
    (6) Evaluating the Evidence of Prescription Digital Therapeutics: A Panel Discussion
  • 10:30 AM – 11:45 AM
    (6) HEOR: What does it Mean to You?
  • 10:30 AM – 11:45 AM
    (7) IRON-ing Out the Details: Beta Thalassemia Landscape, Emerging Treatments, and Payer Considerations
  • 10:30 AM – 11:45 AM
    (8) Federal Legislative and Regulatory Update
  • 10:30 AM – 11:45 AM
    (9) Measuring Medical Cost Offsets from Improvements in Medication Adherence Using Real-World Data
  • 10:30 AM – 11:45 AM
    (10) Challenges and Opportunities in Collecting Data to Address Health Disparities
  • 3:15 PM – 4:30 PM
    Biosimilar Operational Readiness: Current and Future Market Landscape
  • 3:15 PM – 4:30 PM
    (6) Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management
  • 3:15 PM – 4:30 PM
    (7) AMCP Market Insights: Targeted Therapies to Deliver Improved Patient Outcomes in Oncology
  • 3:15 PM – 4:30 PM
    (8) Podium Session – Award-winning Research Supporting the Managed Care Pharmacy Research Agenda
  • 3:15 PM – 4:30 PM
    (9) The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications